Skip to main content
. 2020 Jan 3;34(1):247–253. doi: 10.21873/invivo.11767

Table I. Patient characteristics.

graphic file with name in_vivo-34-250-i0001.jpg

*For <60 vs. ≥60 years old among the three groups. ALKr: Anaplastic lymphoma kinase-rearranged; BMs: brain metastases; ECOG-PS: Eastern Cooperative Oncology Group performance status; EGFR: epidermal growth factor receptor; TKI: tyrosine kinase inhibitor; RT: radiotherapy; STI: stereotactic irradiation; WBRT: whole-brain radiotherapy.